Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 361 - 380 of 454 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of Veliparib Given with Radiation Therapy to the Chest Wall and Lymph Nodes in Patients with Inflammatory or Recurrent Breast Cancer
[Protocol 12-215]
Ho, Alice
A Phase I Study of TRC105 plus Bevacizumab in Patients with Recurrent Glioma
[Protocol 12-217]
Omuro, Antonio
  • Brain Tumors, Primary
    • Gliomas
A Phase I Study of Topical Calcitriol (Compound 31543) to Prevent Hair Loss in Women Receiving Paclitaxel for Advanced Breast Cancer
[Protocol 11-205]
Lacouture, Mario
  • Breast Cancer
A Phase I Study of Tigecycline in Patients with Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-148]
Tallman, Martin
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of the Treatment of Beta-Thalassemia with a Gene Transfer Approach
[Protocol 10-164]
Boulad, Farid
  • Hematology
    • Hematologic Disorders
A Phase I Study of the NY-ESO-1 Vaccine plus Ipilimumab in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-253]
Wolchok, Jedd
  • Melanoma
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
[Protocol 12-230]
Kushner, Brian
  • Neuroblastoma
A Phase I Study of SNX-5422 plus Erlotinib in Patients with Lung Cancer that Has Grown on Erlotinib Therapy
[Protocol 13-035]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
[Protocol 08-091]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of SGN-CD19A in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
[Protocol 12-282]
Moskowitz, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of PU-H71 in Patients with Advanced Cancer
[Protocol 11-041]
Gerecitano, John
  • Lymphoma
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors
[Protocol 12-156]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
  • Thyroid Cancer
A Phase I Study of Plerixafor as a Chemosensitizing Agent for Children with Relapsed Acute Leukemia or Myelodysplastic Syndromes
[Protocol 11-208]
Trippett, Tanya
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of PF-05082566 Alone in Patients with Advanced Cancer, and in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma
[Protocol 11-085]
Segal, Neil
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Pegylated Liposomal Doxorubicin, Carboplatin, and Veliparib in Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
[Protocol 12-197]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020]
Meyers, Paul
A Phase I Study of Oral LEE011 in Patients with Advanced Solid Tumors or Lymphomas
[Protocol 10-211]
Gerecitano, John
  • Lymphoma
A Phase I Study of Oral DS-7423 in Patients with Advanced Solid Tumors
[Protocol 11-144]
Ho, Alan
A Phase I Study of NEOD001 in Patients with Light Chain Amyloidosis
[Protocol 12-280]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase I Study of Narnatumab (IMC-RON8) in Patients with Refractory Solid Tumors
[Protocol 13-018]
Gounder, Mrinal
  • Solid Tumors